01731oam 2200433 450 991070470890332120131205115611.0(CKB)5470000002444640(OCoLC)856545318(EXLCZ)99547000000244464020130821d2013 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierFDA user fees 2012 issues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012Washington :U.S. Government Printing Office,2013.1 online resource (iv, 214 pages) illustrationsTitle from title screen (viewed on Aug. 21, 2013).Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office."Serial no. 112-126."Includes bibliographical references.FDA user fees 2012 Drug approvalUnited StatesGasesTherapeutic useGovernment policyUnited StatesAntibioticsDevelopmentUnited StatesDrugsUnited StatesMarketingDrug approvalGasesTherapeutic useGovernment policyAntibioticsDevelopmentDrugsMarketing.GPOGPOGPOBOOK9910704708903321FDA user fees 20123463567UNINA